首页> 外文会议>AIChE Annual Meeting >GENE EXPRESSION PROFILING OF CD133+ PROSTATE CANCER STEM CELLS INDUCED FROM PC3 CARCINOMA CELL LINE CULTURES
【24h】

GENE EXPRESSION PROFILING OF CD133+ PROSTATE CANCER STEM CELLS INDUCED FROM PC3 CARCINOMA CELL LINE CULTURES

机译:PC3癌细胞系培养诱导的CD133 +前列腺癌干细胞基因表达分析

获取原文

摘要

According to the stem cell model of cancer progression, the disease emerges through mutations and epigenetic modifications that disrupt normal function in adult stem cells. These cancer stem cells (CSCs) constitute a very small subset of the tumor and are responsible for establishing and maintaining the disease. The identification of potential therapeutic targets that are differentially expressed in the normal and malignant stem cell populations has been limited by the lack of suitable in vitro experimental models. We report the implementation of a custom cell culture protocol for the enrichment of the CD133~+ CSC population from PC3 carcinoma cells. When analyzed by flow cytometry, using anti-CD 133 (293C3) labeled antibodies we observed that this side population becomes significantly enriched (up to 5.6% positive events) as compared to standard protocols (0.2%). We further characterized both CD133~+ and CD133~- fractions using novel gene expression-profiling technology. Functional annotation of differentially expressed gene patterns reveals, up-regulation of pathways comprising several genes associated with cell fate as well as DNA repair mechanisms, cell cycle regulation, inhibition of differentiation and metastasis.
机译:根据癌症进展的干细胞模型,疾病通过突变和表观遗传修饰出现,使成年干细胞中的正常功能破坏。这些癌症干细胞(CSCs)构成了肿瘤的非常小的子集,并负责建立和维持疾病。鉴定在正常和恶性干细胞群中差异表达的潜在治疗靶标受到缺乏合适的体外实验模型的限制。我们报告了从PC3癌细胞富集CD133〜+ CSC群的定制细胞培养方案的实施。当通过流式细胞术分析,使用抗CD 133(293C3)标记的抗体,我们观察到与标准方案(0.2%)相比,该侧群显着富集(高达5.6%的阳性事件)。我们进一步用新的基因表达 - 分析技术表征了CD133〜+和CD133〜 - 级分。差异表达基因模式的功能注释显示,途径上调,包括与细胞命运相关的几种基因以及DNA修复机制,细胞周期调节,分化和转移的抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号